-
3 Chronic Therapy Brand Company, Formulations Exporter and Largest Indian Pharma Group Stocks With a Strong Future Roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma
- October 28, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
No Comments
Chronic Brand, Export and Leader Pharma with a strong future roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Active Ingredients Maker, Contract Formulations Company and Branded Generics Leader Stocks With a Strong Future Roadmap: Divi’s Laboratories, Innova Captab and Sun Pharma
- October 28, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Pharma Ingredient, Contract and Generics Stocks with a strong future roadmap: Divi’s Laboratories, Innova Captab and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Chronic Care Brands Company, Cardiac and Central Nervous System Therapy Leader and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Torrent Pharmaceuticals and Sun Pharma
- October 28, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Prescription Brand Leader Pharma Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Torrent Pharmaceuticals and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Branded Generics Exporter, Latin America Focused Drug Maker and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma
- October 28, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Africa, Latin America and Specialty Drug Stocks with a strong future roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
Stocks to Watch Today, 8 October: TCS Results, Tata Steel Q2 Update, Sun Pharma’s Rs 15,000 Crore Debt Plan, Ola Electric Rights Issue, Vedanta Dividend and the GST Council Meeting After a Weak Close
- October 8, 2026
- Posted by: Chaitanya Auti
- Category: News
Stocks to watch today, 8 October: TCS results, Tata Steel update, Sun Pharma debt plan, Ola Electric rights and Vedanta dividend.
-
Sun Pharma results Q2FY23
- November 4, 2022
- Posted by: Sheen Hitaishi
- Category: Market
